{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:26:04Z","timestamp":1790753164008,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T00:00:00Z","timestamp":1407801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00280-014-2552-3","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T08:03:38Z","timestamp":1407744218000},"page":"809-817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Resistance to the antiproliferative effect induced by a short-chain ceramide is associated with an increase of glucosylceramide synthase, P-glycoprotein, and multidrug-resistance gene-1 in cervical cancer cells"],"prefix":"10.1007","volume":"74","author":[{"given":"Gisela","family":"Guti\u00e9rrez-Iglesias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamilec","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Icela","family":"Palma-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"L\u00f3pez-Marure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,12]]},"reference":[{"key":"2552_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.02.020","volume":"264","author":"A Carpinteiro","year":"2008","unstructured":"Carpinteiro A, Dumitru C, Schenck M et al (2008) Ceramide-induced cell death in malignant cells. Cancer Lett 264:1\u201310","journal-title":"Cancer Lett"},{"key":"2552_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1432-1033.2001.01845.x","volume":"268","author":"NS Radin","year":"2001","unstructured":"Radin NS (2001) Killing cancer cells by poly-drug elevation of ceramide levels. A hypothesis whose time has come? Eur J Biochem 268:193\u2013204","journal-title":"Eur J Biochem"},{"key":"2552_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00232-001-0033-1","volume":"181","author":"H Sietsma","year":"2001","unstructured":"Sietsma H, Veldman RJ, Kok JW (2001) The involvement of sphingolipids in multidrug resistance. J Membr Biol 181:153\u2013162","journal-title":"J Membr Biol"},{"key":"2552_CR4","doi-asserted-by":"crossref","first-page":"19530","DOI":"10.1074\/jbc.271.32.19530","volume":"271","author":"Y Lavie","year":"1996","unstructured":"Lavie Y, Cao H, Bursten SL et al (1996) Accumulation of glucosylceramides in multidrug resistant cancer cells. J Biol Chem 271:19530\u201319536","journal-title":"J Biol Chem"},{"key":"2552_CR5","first-page":"475","volume":"18","author":"A Lucci","year":"1998","unstructured":"Lucci A, Cho WI, Han TY (1998) Glucosylceramide: a marker for multiple drug resistant cancers. Anticancer Res 18:475\u2013480","journal-title":"Anticancer Res"},{"key":"2552_CR6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bbalip.2007.09.005","volume":"771","author":"V Gouaz\u00e9-Andersson","year":"2007","unstructured":"Gouaz\u00e9-Andersson V, Yu JY, Kreitenberg AJ et al (2007) Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells. Biochim Biophys Acta 771:1407\u20131417","journal-title":"Biochim Biophys Acta"},{"key":"2552_CR7","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1590\/S0036-36342003000900005","volume":"45","author":"LF Palacio-Mej\u00eda","year":"2003","unstructured":"Palacio-Mej\u00eda LF, Rangel-G\u00f3mez G, Hern\u00e1ndez-Avila M et al (2003) Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Publica Mex 45:S315\u2013S325","journal-title":"Salud Publica Mex"},{"key":"2552_CR8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-291X(02)00315-7","volume":"293","author":"R L\u00f3pez-Marure","year":"2002","unstructured":"L\u00f3pez-Marure R, Guti\u00e9rrez G, Mendoza C et al (2002) Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis. Biochem Biophys Res Commun 293:1028\u20131036","journal-title":"Biochem Biophys Res Commun"},{"key":"2552_CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/CAD.0b013e3280115111","volume":"18","author":"G Guti\u00e9rrez","year":"2007","unstructured":"Guti\u00e9rrez G, Mendoza C, Monta\u00f1o LF et al (2007) Ceramide induces early and late apoptosis in human papilloma virus+ cervical cancer cells by inhibiting reactive oxygen species decay, diminishing the intracellular concentration of glutathione and increasing nuclear factor-kappaB translocation. Anticancer Drugs 18:149\u2013159","journal-title":"Anticancer Drugs"},{"key":"2552_CR10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.cdd.4400796","volume":"8","author":"B Bernard","year":"2001","unstructured":"Bernard B, Fest T, Pr\u00e9tet JL et al (2001) Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle. Cell Death Differ 8:234\u2013244","journal-title":"Cell Death Differ"},{"key":"2552_CR11","first-page":"69","volume":"7","author":"A Monroy","year":"1992","unstructured":"Monroy A, Rangel R, Rocha L et al (1992) Establecimiento de siete estirpes celulares provenientes de biopsias de c\u00e9rvix normal y con c\u00e1ncer c\u00e9rvico-uterino y sus diferentes contenidos y localizaciones de desmogle\u00edna-1. Oncolog\u00eda 7:69\u201376","journal-title":"Oncolog\u00eda"},{"key":"2552_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0003-2697(89)90710-0","volume":"182","author":"W Kueng","year":"1989","unstructured":"Kueng W, Silber E, Eppenberger U (1989) Quantification of cells cultured on 96-well plates. Anal Biochem 182:16\u201319","journal-title":"Anal Biochem"},{"key":"2552_CR13","first-page":"819548","volume":"19","author":"A Rogalska","year":"2014","unstructured":"Rogalska A, Szwed M, Rychlik B (2014) The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cells. Sci World J 19:819548","journal-title":"Sci World J"},{"key":"2552_CR14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1096\/fj.00-0223com","volume":"15","author":"YY Liu","year":"2001","unstructured":"Liu YY, Han TY, Giuliano AE et al (2001) Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J 15:719\u2013730","journal-title":"FASEB J"},{"key":"2552_CR15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbagen.2007.08.010","volume":"1780","author":"S Chatterjee","year":"2008","unstructured":"Chatterjee S, Pandey A (2008) The Yin and Yang of lactosylceramide metabolism: implications in cell function. Biochim Biophys Acta 1780:370\u2013382","journal-title":"Biochim Biophys Acta"},{"key":"2552_CR16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0006-291X(91)91225-2","volume":"181","author":"S Chatterjee","year":"1991","unstructured":"Chatterjee S (1991) Lactosylceramide stimulates aortic smooth muscle cell proliferation. Biochem Biophys Res Commun 181:554\u2013561","journal-title":"Biochem Biophys Res Commun"},{"key":"2552_CR17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1476-4598-9-145","volume":"9","author":"YY Liu","year":"2010","unstructured":"Liu YY, Gupta V, Patwardhan GA et al (2010) Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling. Mol Cancer 9:145","journal-title":"Mol Cancer"},{"key":"2552_CR18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0046-8177(90)90073-E","volume":"21","author":"RS Weinstein","year":"1990","unstructured":"Weinstein RS, Kuszak JR, Kluskens LF et al (1990) P-glycoprotein in pathology: the multidrug resistance gene family in humans. Hum Pathol 21:34\u201348","journal-title":"Hum Pathol"},{"key":"2552_CR19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/07357909009012080","volume":"8","author":"WT Bellamy","year":"1990","unstructured":"Bellamy WT, Dalton WS, Dorr RT (1990) The clinical relevance of multidrug resistance. Cancer Invest 8:545\u2013560","journal-title":"Cancer Invest"},{"key":"2552_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1992.tb04608.x","volume":"82","author":"C Ludescher","year":"1992","unstructured":"Ludescher C, Thaler J, Drach D et al (1992) Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Br J Haematol 82:161\u2013168","journal-title":"Br J Haematol"},{"key":"2552_CR21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0092-8674(94)90147-3","volume":"77","author":"R Kolesnick","year":"1994","unstructured":"Kolesnick R, Golde D (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325\u2013328","journal-title":"Cell"},{"key":"2552_CR22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jcb.240580208","volume":"58","author":"LM Obeid","year":"1995","unstructured":"Obeid LM, Hannun YA (1995) Ceramide: a stress signal and mediator of growth suppression and apoptosis. J Cell Biochem 58:191\u2013198","journal-title":"J Cell Biochem"},{"key":"2552_CR23","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/PL00000836","volume":"58","author":"J Ohanian","year":"2001","unstructured":"Ohanian J, Ohanian V (2001) Sphingolipids in mammalian cell signalling. Cell Mol Life Sci 58:2053\u20132068","journal-title":"Cell Mol Life Sci"},{"key":"2552_CR24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1054\/drup.2001.0225","volume":"4","author":"B Ogretmen","year":"2001","unstructured":"Ogretmen B, Hannun YA (2001) Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance. Drug Resist Updat 4:368\u2013377","journal-title":"Drug Resist Updat"},{"key":"2552_CR25","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1074\/jbc.274.2.1140","volume":"274","author":"YY Liu","year":"1999","unstructured":"Liu YY, Han TY, Giuliano AE et al (1999) Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem 274:1140\u20131146","journal-title":"J Biol Chem"},{"key":"2552_CR26","doi-asserted-by":"crossref","first-page":"33549","DOI":"10.1074\/jbc.M109.031971","volume":"284","author":"S Imgrund","year":"2009","unstructured":"Imgrund S, Hartmann D, Farwanah H et al (2009) Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas. J Biol Chem 284:33549\u201333560","journal-title":"J Biol Chem"},{"key":"2552_CR27","first-page":"133","volume":"18","author":"RE Friedrich","year":"2004","unstructured":"Friedrich RE, Punke C, Reymann A (2004) Expression of multi-drug resistance genes (mdr1, mrp1, bcrp) in primary oral squamous cell carcinoma. In Vivo 18:133\u2013147","journal-title":"In Vivo"},{"key":"2552_CR28","doi-asserted-by":"crossref","first-page":"H400","DOI":"10.1152\/ajpheart.01254.2008","volume":"297","author":"H Mu","year":"2009","unstructured":"Mu H, Wang X, Wang H et al (2009) Lactosylceramide promotes cell migration and proliferation through activation of ERK1\/2 in human aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 297:H400\u2013H408","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2552_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ijc.1449","volume":"94","author":"H Morjani","year":"2001","unstructured":"Morjani H, Aouali N, Belhoussine R et al (2001) Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets. Int J Cancer 94:57\u201365","journal-title":"Int J Cancer"},{"key":"2552_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ijc.1301","volume":"93","author":"RS Olshefski","year":"2001","unstructured":"Olshefski RS, Ladisch S (2001) Glucosylceramide synthase inhibition enhances vincristine-induced cytotoxicity. Int J Cancer 93:131\u2013138","journal-title":"Int J Cancer"},{"key":"2552_CR31","first-page":"942","volume":"6","author":"H Sietsma","year":"2000","unstructured":"Sietsma H, Veldman RJ, Kolk D et al (2000) 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizers neuroblastoma cells for taxol and vincristine. Clin Cancer Res 6:942\u2013948","journal-title":"Clin Cancer Res"},{"key":"2552_CR32","first-page":"205","volume":"1","author":"JA Shabbits","year":"2002","unstructured":"Shabbits JA, Mayer LD (2002) P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs. Mol Cancer Ther 1:205\u2013213","journal-title":"Mol Cancer Ther"},{"key":"2552_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jnci\/93.5.347","volume":"93","author":"A Senchenkov","year":"2001","unstructured":"Senchenkov A, Litvak DA, Cabot MC (2001) Targeting ceramide metabolism\u2014a strategy for overcoming drug resistance. J Natl Cancer Inst 93:347\u2013357","journal-title":"J Natl Cancer Inst"},{"key":"2552_CR34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1096\/fj.01-0863fje","volume":"16","author":"RJ Veldman","year":"2002","unstructured":"Veldman RJ, Klappe K, Hinrichs J et al (2002) Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus. FASEB J 16:1111\u20131113","journal-title":"FASEB J"},{"key":"2552_CR35","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1074\/jbc.M207269200","volume":"278","author":"A Prinetti","year":"2003","unstructured":"Prinetti A, Basso L, Appierto V et al (2003) Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells. J Biol Chem 278:5574\u20135583","journal-title":"J Biol Chem"},{"key":"2552_CR36","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.4161\/cbt.8.12.8374","volume":"8","author":"X Zhang","year":"2009","unstructured":"Zhang X, Li J, Qiu Z et al (2009) Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi). Cancer Biol Ther 8:1117\u20131121","journal-title":"Cancer Biol Ther"},{"key":"2552_CR37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.leukres.2007.07.006","volume":"32","author":"P Xie","year":"2008","unstructured":"Xie P, Shen YF, Shi YP et al (2008) Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Leuk Res 32:475\u2013480","journal-title":"Leuk Res"},{"key":"2552_CR38","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-04-2329","volume":"65","author":"V Gouaz\u00e9","year":"2005","unstructured":"Gouaz\u00e9 V, Liu YY, Prickett CS et al (2005) Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Cancer Res 65:3861\u20133867","journal-title":"Cancer Res"},{"key":"2552_CR39","first-page":"1","volume":"53","author":"YL Sun","year":"2006","unstructured":"Sun YL, Zhou GY, Li KN et al (2006) Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells. Neoplasma 53:1\u20138","journal-title":"Neoplasma"},{"key":"2552_CR40","doi-asserted-by":"crossref","first-page":"e6938","DOI":"10.1371\/journal.pone.0006938","volume":"4","author":"GA Patwardhan","year":"2009","unstructured":"Patwardhan GA, Zhang QJ, Yin D et al (2009) A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis. PLoS One 4:e6938","journal-title":"PLoS One"},{"key":"2552_CR41","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1074\/jbc.M305645200","volume":"279","author":"MF Rosa De","year":"2004","unstructured":"De Rosa MF, Sillence D, Ackerley C et al (2004) Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis. J Biol Chem 279:7867\u20137876","journal-title":"J Biol Chem"},{"key":"2552_CR42","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.yexcr.2011.03.004","volume":"317","author":"JV Chapman","year":"2011","unstructured":"Chapman JV, Gouaz\u00e9-Andersson V, Karimi R et al (2011) P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells. Exp Cell Res 317:1736\u20131745","journal-title":"Exp Cell Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2552-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-014-2552-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2552-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T19:19:43Z","timestamp":1565723983000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-014-2552-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1007\/s00280-014-2552-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,12]]}}}